Long-term results of adjuvant hormonal therapy plus radiotherapy following radical prostatectomy for patients with pT3N0 or pT3N1 prostate cancer

International Journal of Urology

Volumn 11, Issue 6, 2004, Pages 397-401

  Miyake, Hideaki ^a   Sakai, Iori ^a   Harada, Ken Ichi ^a   Hara, Isao ^b   Eto, Hiroshi ^a  

^a HYOGO MEDICAL CENTER FOR ADULTS   (Japan)

^b KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Adjuvant therapy; Androgen suppression; Locally advanced prostate cancer; Radiation

Indexed keywords

GONADORELIN DERIVATIVE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BEAM THERAPY; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; LONG TERM CARE; MALE; ORCHIECTOMY; PELVIS LYMPHADENECTOMY; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; RADIATION DOSE; SURVIVAL RATE;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, HORMONAL; CHEMOTHERAPY, ADJUVANT; GONADOTROPIN-RELEASING HORMONE; HUMANS; LYMPH NODE EXCISION; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PELVIS; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 3042784678     PISSN: 09198172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2004.00819.x     Document Type: Article

References (20)

1. Paulson DF. Impact of radical prostatectomy in the management of clinically localized disease. J. Urol. 1994; 152: 1826-30.
2. Ohori M, Wheeler TM, Kattan MW et al. Prognostic significance of positive surgical margin in radical prostatectomy specimens. J. Urol. 1995; 154: 1818-24.
3. Watson RB, Civantos F, Soloway MS. Positive surgical margins with radical prostatectomy: detailed pathological analysis and prognosis. Urology 1996; 48: 80-90.
4. D'Amico AV, Whittington R, Malkowicz SB et al. A multivariate analysis of clinical and pathological factors that predict for prostate specific antigen failure after radical prostatectomy for prostate cancer. J. Urol. 1995; 154: 139-58.
5. Zincke H, Lau W, Bergstralh E et al. Role of early adjuvant hormonal therapy after radical prostatectomy for prostate cancer. J. Urol. 2001; 166: 2208-15.
6. Petrovich Z, Lieskovsky G, Langholz B et al. Adjuvant radiotherapy in patients with pathologic stage C (pT3N0) adenocarcinoma of the prostate. Urology 1999; 53: 1184-93.
7. Leibovich BC, Engen DE, Patterson DE et al. Benefit of adjuvant radiation therapy for localized prostate cancer with a positive surgical margin. J. Urol. 2000; 163: 1178-82.
8. Corn BW, Winter K, Pilepich MV. Does androgen suppression enhance the efficacy of postoperative irradiation? A secondary analysis of RTOG 85-31. Urology 1999; 54: 495-502.
9. International Union Against Cancer. TNM Classification of Malignant Tumors, 5th edn. John Wiley & Sons, New York, USA, 1997.
10. Catalona WJ, Smith DS. Cancer recurrence and survival rates after anatomic radical retropubic prostatectomy for prostate cancer: intermediate-term results. J. Urol. 1998; 160: 2428-34.
11. Partin AW, Kattan MW, Subrong EN et al. Combination of prostate specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. JAMA 1997; 277: 1445-51.
12. Bolla M, Gonzalez D, Warde P et al. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. N. Engl. J. Med. 1997; 337: 295-300.
13. Lawton CA, Winter K, Byhardt R et al. Androgen suppression plus radiation versus radiation alone for patients with D1 (pN+) adenocarcinoma of the prostate: results based on a national prospective randomized trial (RTOG 85-31). Int. J. Radiat. Oncol. Biol. Phys. 1997; 38: 931-9.
14. Laverdiere J, Gomez JL, Cusan L et al. Beneficial effect of combined hormonal therapy administration prior to and following external beam radiation therapy in localized prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 1997; 37: 247-52.
15. Mayer R, Pummer K, Quehenberger F et al. Postprostatectomy radiotherapy for high-risk prostate cancer. Urology 2000; 59: 732-9.
16. Nudell DM, Grossfeld GD, Weinberg VK et al. Radiotherapy after radical prostatectomy: treatment outcomes and failure patterns. Urology 1999; 54: 1049-57.
17. McCarthy JF, Catalona WJ, Hudson MA. Effect of radiation therapy on detectable serum prostate specific antigen levels following radical prostatectomy: early versus delayed treatment. J. Urol. 1994; 151: 1575-8.
18. Gibbons RP, Cole BS, Richardson RG et al. Adjuvant radiotherapy following radical prostatectomy: results and complications. J. Urol. 1986; 135: 65-8.
19. Syndikus I, Pickles T, Kostashuk E et al. Postoperative radiotherapy for stage T3 carcinoma of the prostate: improved local control. J. Urol. 1996; 155: 1983-6.
20. Epstein IJ. Incidence and significance of positive margins in radical prostatectomy specimens. Urol. Clin. North Am. 1996; 23: 651-63.